Search

Your search keyword '"Ogata, Hidenori"' showing total 256 results

Search Constraints

Start Over You searched for: Author "Ogata, Hidenori" Remove constraint Author: "Ogata, Hidenori"
256 results on '"Ogata, Hidenori"'

Search Results

1. Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial

2. Method of Fundamental Solutions for Doubly Periodic Potential Problems

3. A method of fundamental solutions for doubly-periodic potential flow problems using the Weierstrass elliptic function

4. Method of fundamental solutions for the problem of doubly-periodic potential flow

5. Numerical method of computing Hadamard finite-part integrals with a non-integral power singularity at the endpoint over a half infinite interval

6. A numerical method of computing Hadamard finite-part integrals with an integral power singularity at the endpoint on a half infinite interval

7. Numerical method for computing Hadamard finite-part integrals with a non-integral power singularity at an endpoint

8. A numerical method for Hadamard finite-part integrals with an integral power singularity at an endpoint

9. A numerical method of computing oscillatory integral related to hyperfunction theory

10. An analog of the Sinc approximation for periodic functions

11. A numerical method of Fourier transform based on hyperfunction theory

18. Focal 18F‐fluorodeoxyglucose uptake in spinal dural arteriovenous fistula: A report of two cases.

21. Anti-LGI4 Antibody Is a Novel Juxtaparanodal Autoantibody for Chronic Inflammatory Demyelinating Polyneuropathy

25. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti‐neurofascin155 immunoglobulin G4 antibody

34. Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke A Randomized Clinical Trial and Meta-analysis

36. The Oldest Japanese Case of Combined Central and Peripheral Demyelination, which Developed Nine Years After the First Instance of Optic Neuritis

43. Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

49. Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy

Catalog

Books, media, physical & digital resources